Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (241-250 of 340) with videos related to

Pageof 34
Sort By:
Digestive Diseases (Basel, Switzerland)|February 7, 2019
Unmet Medical Needs in Ulcerative Colitis: An Expert Group ConsensusSilvio Danese, Matthieu Allez, Ad A van Bodegraven, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
BMJ Open Gastroenterology|February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitisEdouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research|April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitisJae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
Expert Review of Gastroenterology & Hepatology|September 3, 2024
Practical management of mild-to-moderate ulcerative colitis: an international expert consensusFerdinando D'Amico, Fernando Magro, Axel Dignass, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2025
Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysisMohammad Al Hayek, Mohammed S Beshr, Mohamedhen Vall Nounou, et al.
Medical Microbiology and Immunology|May 22, 2015
Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel diseaseNair Nazareth, Fernando Magro, Elisabete Machado, et al.
Journal of Crohn'S & Colitis|March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel DiseaseAxel Dignass, Neeraj Narula, Krishan Pratap, et al.
Scandinavian Journal of Gastroenterology|December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitisAxel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Pageof 34

Showing results (241-250 of 340) with videos related to

Sort By:
Pageof 34
Digestive Diseases (Basel, Switzerland)|February 7, 2019
Unmet Medical Needs in Ulcerative Colitis: An Expert Group ConsensusSilvio Danese, Matthieu Allez, Ad A van Bodegraven, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
BMJ Open Gastroenterology|February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitisEdouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research|April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitisJae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
Expert Review of Gastroenterology & Hepatology|September 3, 2024
Practical management of mild-to-moderate ulcerative colitis: an international expert consensusFerdinando D'Amico, Fernando Magro, Axel Dignass, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2025
Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysisMohammad Al Hayek, Mohammed S Beshr, Mohamedhen Vall Nounou, et al.
Medical Microbiology and Immunology|May 22, 2015
Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel diseaseNair Nazareth, Fernando Magro, Elisabete Machado, et al.
Journal of Crohn'S & Colitis|March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel DiseaseAxel Dignass, Neeraj Narula, Krishan Pratap, et al.
Scandinavian Journal of Gastroenterology|December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitisAxel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Pageof 34